PsychiatryLive

The new face of Psychiatric Times. Premier content, written by and for #mentalhealth physicians and professionals. Questions? Email: [email protected].

[PsychiatryLive @Psychiatry_Live]

How is schizophrenia management evolving? Attend our live national broadcast to explore real-world strategies to manage side effects, support treatment persistence, and optimize long-term functional
outcomes in schizophrenia. Register Today! https://t.co/omw6He3wRc

[PsychiatryLive @Psychiatry_Live]

Oveporexton (Orzeyful) is now available in the US by prescription for the treatment of narcolepsy type 1 in adults. This is the first and only orexin agonist for this indication. https://t.co/X2ibhBsbWn

[PsychiatryLive @Psychiatry_Live]

Where do OCD and schizophrenia overlap, complicating diagnosis and care? https://t.co/e2LegDLmJK

[PsychiatryLive @Psychiatry_Live]

The first participant has been dosed in the Brexanolone Lifting Outcomes of Moms (BLOOM) study, @LipocineInc's phase 3 trial evaluating LPCN 1154 for postpartum depression. https://t.co/KuX07qFDaZ

[PsychiatryLive @Psychiatry_Live]

🚨 @COMPASSPathway have completed their submission of an NDA for COMP360 psilocybin for treatment-resistant depression.

If approved, COMP360 would become the first classic psychedelic medicine ever approved by the FDA. https://t.co/sgTfbXiiCQ

[PsychiatryLive @Psychiatry_Live]

Our November theme: Emergency Psychiatry.

If you are interested in being featured in a future Special Report/print issue, submit to our content series! https://t.co/mXRadXxzJR

[PsychiatryLive @Psychiatry_Live]

Big news: Psychiatric Times is now PsychiatryLive! 🧠

After 40+ years of psychiatric coverage, we're building on that legacy with more real-time news, video, live events, and expert perspectives.

Same team. Same commitment. A new name for what's next.

https://t.co/VYFKxYov1B

[PsychiatryLive @Psychiatry_Live]

The November issue of Psychiatric Times is now live! This month, we examine the uses of GLP-1s in psychiatry.

Download the issue now and follow along as articles are shared throughout the month. https://t.co/VVNLXfnIXv

[PsychiatryLive @Psychiatry_Live]

We're excited to welcome Lumin Health as a new Strategic Alliance Partner of PsychiatryLive!

Together, we're bringing clinicians more insights, resources, and support to advance mental health care.

Learn more: https://t.co/hcFrMb49bE

#Psychiatry #MentalHealth #SAP

[PsychiatryLive @Psychiatry_Live]

November is Alzheimer’s Awareness Month. Explore the latest clinical insights, research, and perspectives on Alzheimer disease and dementia from Psychiatric Times.

🔗https://t.co/xr1eIIA7EW

[PsychiatryLive @Psychiatry_Live]

How is schizophrenia management evolving? Attend our live national broadcast to explore real-world strategies to manage side effects, support treatment persistence, and optimize long-term functional outcomes in schizophrenia. Register Today! https://t.co/omw6He3wRc

[PsychiatryLive @Psychiatry_Live]

Is your adult ADHD patient covered from morning to night? Our expert panel talks treatment selection, all-day symptom control, adherence, and when to add a non-stimulant. https://t.co/Ude6Atit2R #ADHD #Psychiatry

[PsychiatryLive @Psychiatry_Live]

In this week's episode of "Psyched Perspectives," host @tapkidmd and guest Diego Regalado, MD, discuss immigrant mental health and the importance of cultural humility. https://t.co/LVQsh0H3jF

[PsychiatryLive @Psychiatry_Live]

🧠 Today is #InternationalStutteringAwarenessDay.

This year, we shared the first ever interdisciplinary consensus guidelines on stuttering.

🔗 Read them here: https://t.co/NbbKK7gtsM

[PsychiatryLive @Psychiatry_Live]

🎃 The entire October issue of Psychiatric Times is now live on our website. Read it here: https://t.co/tsCdjxBcS4

[PsychiatryLive @Psychiatry_Live]

In our latest CME article, learn how to recognize historical and persistent barriers to the ethical use of long-acting injectable antipsychotics. https://t.co/6v9BSEVW1U

[PsychiatryLive @Psychiatry_Live]

Adult ADHD is more common than many clinicians think, and symptoms often look nothing like the childhood picture. Drs. Lentzsch-Parcells, Patel, and Feld break down diagnosis, comorbidities, and burden in our new Peer Exchange. https://t.co/NxqGd1hLFC #ADHD

[PsychiatryLive @Psychiatry_Live]

According to a new review, ADHD medications may help improve brain fog in perimenopausal women. https://t.co/Nrx0mwwzwv

[PsychiatryLive @Psychiatry_Live]

🎙️ Episode 2 of The Psych Consult: Second Opinion is here!

Claire Brandon, MD, and endocrinologist Caroline Messer, MD, discuss where thyroid disease and psychiatric illness overlap.

🔗 https://t.co/KVJNdtN4Sl

[PsychiatryLive @Psychiatry_Live]

🦠 Phase 2 signal-finding trial of bezisterim for the treatment of long COVID shows safety and symptom gains, with strongest benefits for severe fatigue, post-exertional malaise, and cognitive issues. https://t.co/vg5nIDaPIu